| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net sales | $292.5M-3.8% | $303.9M-10.3% | $338.8M+7.1% | $316.2M+8.7% | $291.0M+10.2% | $264.2M-2.4% | $270.6M+3.4% | $261.7M |
| Cost of sales (exclusive of intangible amortization) | $134.8M-9.7% | $149.2M-9.3% | $164.5M+9.3% | $150.5M+12.1% | $134.2M+17.9% | $113.9M-0.7% | $114.6M-2.7% | $117.8M |
| Gross margin | $157.7M+1.9% | $154.7M-11.2% | $174.2M+5.1% | $165.7M+5.7% | $156.8M+4.3% | $150.3M-3.7% | $156.0M+8.4% | $143.9M |
| Research and development | $26.2M-16.8% | $31.5M+5.5% | $29.9M-2.8% | $30.7M-15.5% | $36.4M+22.6% | $29.7M+5.0% | $28.3M+16.1% | $24.3M |
| Sales and marketing | $103.1M+0.3% | $102.8M-1.4% | $104.2M+9.4% | $95.3M+17.2% | $81.3M+3.4% | $78.6M+2.3% | $76.8M+5.1% | $73.1M |
| General and administrative | $42.1M+2.3% | $41.2M+2.9% | $40.0M+4.0% | $38.5M+7.1% | $35.9M-5.2% | $37.9M+8.5% | $34.9M+12.6% | $31.0M |
| Amortization of intangibles | $10.3M-20.9% | $13.0M-30.6% | $18.8M-3.4% | $19.5M+7.3% | $18.1M+0.1% | $18.1M+6.2% | $17.1M+22.7% | $13.9M |
| Goodwill impairment | $0-100.0% | $159.5M+996.1% | $14.5M | $0 | $0-100.0% | $158.6M | $0 | $0 |
| Change in fair value of contingent consideration | $272K-37.0% | $432K-81.4% | $2.3M+91.4% | $1.2M+1261.8% | $89K+100.8% | -$11.5M-70.2% | -$6.8M-2810.4% | $250K |
| Acquisition, restructuring and other items, net | $15.6M-70.6% | $53.2M+240.2% | $15.6M+72.9% | $9.0M-55.3% | $20.2M+236.4% | $6.0M-60.2% | $15.1M-2.0% | $15.4M |
| Total operating expenses | $197.7M-50.8% | $401.6M+78.2% | $225.4M+16.1% | $194.2M+1.1% | $192.1M-39.5% | $317.4M+91.9% | $165.4M+4.7% | $158.0M |
| Gain on sale of assets | $0-100.0% | $54.5M | $0 | $0 | — | — | — | — |
| Operating loss | -$40.0M+79.2% | -$192.4M-276.0% | -$51.2M-79.8% | -$28.5M+19.3% | -$35.3M+78.9% | -$167.1M-1678.4% | -$9.4M+33.7% | -$14.2M |
| Interest income (expense), net | $978K-39.4% | $1.6M+159.7% | -$2.7M-292.7% | -$688K | — | — | — | — |
| Other income (expense), net | $4.9M+705.1% | -$817K-47.5% | -$554K+29.9% | -$790K-958.7% | $92K+170.8% | -$130K+37.2% | -$207K+93.3% | -$3.1M |
| Total other income (expense), net | $5.9M+643.0% | $797K+124.5% | -$3.3M-120.3% | -$1.5M-92.2% | -$769K+25.8% | -$1.0M+80.5% | -$5.3M | — |
| Loss before income tax benefit | -$34.0M+82.2% | -$191.6M-252.0% | -$54.4M-81.8% | -$29.9M+16.9% | -$36.1M+78.6% | -$168.1M | — | — |
| Income tax benefit | -$39K+99.5% | -$7.3M-265.4% | -$2.0M+41.4% | -$3.4M+24.5% | -$4.5M-234.1% | -$1.3M+62.1% | -$3.6M+67.8% | -$11.0M |
| Net loss | -$34.0M+81.6% | -$184.3M-251.5% | -$52.4M-97.5% | -$26.5M+15.9% | -$31.5M+81.1% | -$166.8M-371.9% | $61.3M+275.5% | $16.3M |
| Basic (usd per share) | -$830.00+81.9% | -$4590.00-245.1% | -$1330.00-95.6% | -$680.00-82826.8% | -$0.82+81.3% | -$4.39-367.7% | $1.64-99.6% | $440.00 |
| Diluted (usd per share) | -$830.00+81.9% | -$4590.00-245.1% | -$1330.00-95.6% | -$680.00-82826.8% | -$0.82+81.3% | -$4.39-367.7% | $1.64-99.6% | $440.00 |
| Basic (in shares) | 40.85B+1.7% | 40.18B+1.8% | 39.48B+1.2% | 39.01B+101639.4% | 38.3M+1.0% | 38.0M+1.3% | 37.5M-99.9% | 37.07B |
| Diluted (in shares) | 40.85B+1.7% | 40.18B+1.8% | 39.48B+1.2% | 39.01B+101639.4% | 38.3M+1.0% | 38.0M+1.3% | 37.5M-99.9% | 37.07B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.